Exelixis Inc (EXEL)
36.71
+1.62
(+4.62%)
USD |
NASDAQ |
Feb 21, 15:48
Exelixis Market Cap: 10.27B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Halozyme Therapeutics Inc | 7.086B |
Incyte Corp | 14.02B |
Alnylam Pharmaceuticals Inc | 32.19B |
Biomarin Pharmaceutical Inc | 12.97B |
Catalyst Pharmaceuticals Inc | 2.585B |
Market Cap Related Metrics
PE Ratio | 20.74 |
PS Ratio | 5.013 |
PEG Ratio | 0.1184 |
Price to Book Value | 4.578 |
Price to Free Cash Flow | 17.15 |
Price | 36.71 |
Earnings Yield | 4.82% |
PEGY Ratio | 0.1184 |
Operating PE Ratio | 15.76 |
Normalized PE Ratio | 18.46 |